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 e determinants of human athletic performance 
have long been a challenging  eld of study in sport 
sciences. Sports performance is an enormously complex 
multifactorial phenomenon, and is determined by 
numerous intrinsic (e.g., genetics, motor behavior, 
physiological and psychological pro le) and extrinsic 
factors (e.g., training, nutrition, development 
opportunities and overall health conditions) as well 
as by the interaction between them1. Although it is 
impossible to set a unique formula to make anyone 
becoming a successful athlete, it is widely accepted 
that any individual who is highly committed and 
dedicated to training is able to improve athletic 
performance. Likewise, to be a top-level athlete, 
several years of dedication to an organized and rigid 
training system is indeed a prerequisite, although 
not a guarantee of success. However, a few athletes 
seem to be exceptionally gifted and demonstrate 
extraordinarily high performance levels even before 
taking part in training programs; some athletes 
demonstrate better responses to training than others, 
or may be able to consistently sustain high levels of 
performance over their competitive career2-3.
Despite the awareness of the genetic in uences on 
competitive success, genetics of sports performance is 
a quite recent area of investigation. As a consequence, 
the currently available knowledge is largely incipient 
and some authors consider we are at infant stages of 
the area4. Hence, every e ort aiming at improving 
our understanding on this phenomenon is of great 
importance.
 e earlier studies on genetics of human performance 
were focused on estimating the heritability of di erent 
complex traits. Using approaches such as twin-studies 
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and familial aggregation studies, investigators were 
able to estimate the percentage contribution of 
genetic factors to muscle fibre type distribution 
and enzyme activities5-6, bone density and muscle 
strength7, aerobic8 and anaerobic capacities9, among 
other performance-relevant variables. Although 
unquestionably relevant, these studies did not provide 
speci c information on which particular genes and 
genetic variants would be involved in such genetic 
in uences.  e  rst polymorphism related to sport 
performance (i.e., angiotensin-conversion enzyme, 
ACE) was not identi ed until 1998 10-11. 
Over the past 15 years, the advances in 
biotechnology and molecular biology tools have 
facilitated a rapid increase in the identi cation of 
structural genetic variations capable of exerting 
some in uence on the phenotypes related to athletic 
performance12. Association studies made possible the 
establishment of a human gene map for exercise13 
and constant updates re ect the rapid increase in 
the number of polymorphisms that entered in this 
map14-15. To date, more than 200 polymorphisms 
have been associated with some feature related to 
physical exercise15, and it is expected that this number 
will increase in the following years15. However, 
only about 20 of these >200 genetic variants were 
speci cally observed in athletes4. Furthermore, most 
of these genes and variants have failed to con rm 
association in replication studies16, so that less than 
10 genetic variants have been consistently associated 
Basic concepts
with sports performance17. Considering that the 
human genome has over 20,000 genes and that 
each gene may present an enormous diversity of 
common variants that could theoretically in uence 
some performance-related phenotype, it is extremely 
likely that our currently knowledge represents only 
a small fraction of the genetic factors that in uence 
sports performance. Hence, numerous new genetic 
variants are yet to be discovered, and we still barely 
understand how genes interact with each other and 
with environmental factors. 
High-level sports performance is an extremely 
complex phenotype and genetic background is only 
one of its multiple contributory factors. It is likely 
that the contribution of heritability to a particular 
phenotype will largely depend on the speci c sport 
discipline, among other factors. Even if only the 
genetic factors are considered, sports success remains 
an extremely complex phenomenon because it is a 
multigenic trait18.
Understanding the in uence of genetics in sport 
is a critical step to unravel the determinants of sports 
excellence. However, the challenges are enormous 
and the experimental approaches to address this 
highly complex and multifaceted phenotype are 
somewhat limited. In this critical review, we discuss 
the potential and limitations of research methods on 
genetics of sports performance, the implications of 
this knowledge in “real-world” sport settings, as well 
as directions for future researchs.
For the bene t of reader, the terms and concepts 
most important for understanding this discussion 
are brie y revised below.
Genome refers to the entire collection of genetic 
material hereditarily transmitted to the next 
generation that a given species possesses19. In the case 
of most eukaryotes, including humans, the genome 
is encoded in DNA sequences.  ese sequences are 
composed by four di! erent nitrogen bases (Adenine, 
 ymine, Cytosine and Guanidine - A, T, C and G, 
respectively) that, by binding in sequence, make a 
single DNA strand (e.g., AACGGT is a sequence of 
nitrogen bases forming a single-stranded DNA). Each 
nitrogen base also binds to its complimentary base 
(i.e., A binds to T and C binds to G) so that a single 
DNA strand is attached to a complimentary single 
DNA strand, forming a double-stranded DNA.  e 
DNA molecules are predominantly found inside 
the nucleus, although a small portion is also found 
inside mitochondria. Inside the nucleus, the genome 
is organized in 23 di! erent pairs of chromosomes.
 e human genome has over 3 billion nitrogen base 
pairs. Of this total, only ~5% are encoding regions. 
A gene is considered a speci c region of the genome 
whose DNA sequence encodes a biologically active 
product, which is, in most cases, a RNA molecule that 
ultimately results in a protein. Every individual has 
two copies of each gene, which are called alleles. In the 
coding sequences, a sequence of 3 nucleotides encodes 
for 1 speci c amino acid, which will take place in the 
peptide chain.  ese 3-nucleotide sequences encoding 
for 1 amino acid are called codons. 
Although all human beings share all the same 
genes, they display some slight structural variations in 
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their nitrogen base sequences. It is estimated that only 
0.1% of the genome varies between individuals20. 
However, this minor portion of the genome explains 
the enormous phenotypic diversity that exists among 
humans.  ese variations may occur as: 1) changes 
in a single base pair (for example, in the sequence 
AACGGT the nucleotide G is swapped by a 
nucleotide A, so the variant sequence is AACAGT); 
2) deletions of a single base pair (for example, in the 
sequence AACGGT, the nucleotide G is deleted, 
so the variant sequence is AACGT); 3) insertions 
of single base pairs (for example, in the sequence 
AACGGT, the nucleotide C is inserted, so the variant 
sequence is AACCGT); or 4) changes, deletions 
or insertions in two or more base pairs.  e most 
common type of variation in the human genome 
consists in a change in a single base pair21.  is type 
of variant can be a single nucleotide polymorphism 
(SNP) or a point mutation, depending on how 
prevalent it is in the population and on the impact 
it has on phenotype (see further discussion). 
Despite being non-coding sequences, 95% of the 
genome do play fundamental physiological roles, 
especially by regulating the rate of genes expression 
(i.e., whether or not a gene will be transcribed into 
RNA to produce a protein, and how much RNA will 
be produced from its corresponding gene).  erefore, 
genetic variants may encompass both coding and 
non-coding regions of the genome22. Genetic variants 
that occur in coding regions may a ect the sequence 
of amino acids in a protein and, depending on the 
type of variant, the protein structure can be slightly 
or severely a ected. Obviously, the more a protein 
structure is a ected, the greater its physiological 
impact tends to be.  e variant protein may be 
less functional or even not functional at all. On the 
other hand, when genetic variants occur in non-
coding regions of the genome, the protein structure 
is normally una ected and its physiological impact 
tends to be less pronounced. In these cases, it is more 
likely that the rate of the gene expression is a ected.
Some genetic variations are rare and some are 
common. When a variant appears in less than 1% of 
the population, it is considered a mutation; when its 
frequency in the population is greater than 1%, it is 
considered a polymorphism19. Normally, a mutation 
has a greater impact on physiological functions than 
a polymorphism23. As a consequence, mutations tend 
to have some health impact whereas polymorphisms 
tend to account for normal phenotypic variation. 
However, there are cases of rare mutations that do 
not lead to a disease, as well as there are common 
polymorphisms that increase the likelihood of 
an individual to develop a disease. Whether 
these variants should be considered mutations or 
polymorphisms is still a matter under debate and 
are not under the scope of this review.
As discussed earlier, there are two copies of each 
gene in the genomea. One allele is found in a speci c 
region of a speci c chromosome whilst the other 
allele (which is exactly the same gene but not formed 
by exactly the same sequence) is found in the same 
region of the homologous chromosome. Considering 
a given variation in a given gene, an individual may 
have one or two copies of the most frequent variant 
(which is often referred as the “normal” copy) and/or 
one or two copies of the least frequent variant (which 
is often referred as the polymorphic or mutated copy). 
 erefore, for this speci c variation, the genotype of 
an individual can be: 1) homozygous (two alleles of a 
“normal” copy of the gene); 2) heterozygous (one allele 
of a “normal” copy and the other of a polymorphic 
copy of the gene); or 3) homozygous (two alleles of a 
polymorphic or mutated copy of the gene).
Phenotypic traits are observable characteristics 
controlled by genes.  us, a given genotype a ects 
a given phenotype to some extent. Some traits are 
controlled by one single gene, and they are referred 
to as monogenic traits. Normally, it is relatively 
easy to establish a link between a genotype and 
a phenotype in monogenic traits since they obey 
the Mendelian logic of inheritance. On the other 
hand, polygenic traits are far more complex because 
they are in uenced by several genes, as well as by 
multiple non-genetic environmental factors. Due 
to its multifactorial nature, it is normally di$  cult 
to establish a strong association between one single 
genetic variant and a complex phenotype, which 
often imposes a hurdle to the studies attempting 
to identify speci c genes that in uence a complex 
phenotype.  is explains, at least in part, why 
the associations between genetic polymorphisms 
and athletic performance are normally weak and 
frequently not con rmed in replication studies.
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Experimental approaches 
for studying genetics of sport performance
Genetic inﬂ uences on quantitative traits 
and sports performance
Sports performance is an extremely complex 
phenotypic trait, which is in turn influenced, 
although not determined, by many other traits, 
such as muscle  bre type distribution, aerobic power 
and capacity, anaerobic power and capacity, and 
trainability of physical capacities24. 
Most traits that are relevant to sports performance 
are quantitative, meaning that they are possible to 
be measured and quanti ed. Some examples of 
quantitative traits that are relevant to physical 
performance are: body composition, aerobic power 
and muscle strength. In some cases, the  nal outcome 
of sport performance can also be a quantitative trait. 
For examples, swimming distance times, running 
races, jumps, throws and all other sports in which 
 nal performance is quanti able can be considered 
quantitative traits. In other cases, however, sports 
performance “per se” is not a quantitative trait.  is 
is the case of unpredictable sports, such as team 
sports, individual sports that depend on natures’ 
conditions (e.g., sur ng and sailing) and individual 
sports that depend on opponents’ actions (e.g., 
combat sports).  eoretically, some performance-
relevant quantitative traits are strongly in uence 
by genetic factors, which is also the case of some 
“predictable sports” (FIGURE 1). On the other 
hand, other traits as well as “unpredictable sports” 
are less in uenced by genetic factors (FIGURE 1) 
and, therefore, genotype-phenotype relationships 
are less likely to be established.  is must be kept 
in mind when performing association studies, as 
latter discussed in this review.
FIGURE 1 - Contribution of genetic factors to performance-relevant quantitative traits.
Over the past 15 years, there has been a great e! ort 
to identify, at the molecular level, variations in DNA 
sequence that may contribute to sports performance 
or to any trait that is relevant to sport performance, 
so-called genotype-phenotype correlations. However, 
in complex polygenic multifactorial traits, genotype-
phenotype correlations are often elusive and di"  cult 
to be clearly identi ed.
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Candidate genes association studies
One of the most frequent experimental approaches 
for assessing genotype-phenotype correlations 
is the genetic association. In genetic association 
studies, a candidate polymorphism is correlated 
with a performance-relevant trait. For example, 
the frequency of a candidate polymorphism is 
compared between two highly distinct populations: 
elite athletes and non-athletes. If the polymorphism 
is significantly more frequent in the athletic 
group, it is assumed that this polymorphism is 
associated with athletic status and contributes to 
elite performance. In general, a polymorphism is 
considered a candidate based on the physiological 
role of the gene and on how the di erence in 
nucleotide sequence a ects gene function and/or 
expression.
Association studies can be divided into three 
main categories: 1) case-control studies, which 
compare the frequency of genotypes in a cohort of 
controls (non-athletes) and a cohort of elite athletes; 
2) cross-sectional studies, which compare selected 
physiological and/or performance data between 
di erent genotypes25 and 3) longitudinal studies, in 
which responses to a given intervention (e.g., exercise 
training or diet) are compared between genotype 
groups. All approaches are important to demonstrate 
the relevance of a genetic variant to performance26. 
However, polymorphisms emerging from association 
studies remain as “candidate” genetic variants until 
the association is replicated in other independent 
cohorts and a plausible biological explanation for 
the impact of the polymorphism is formulated25.
Case-control association studies are relatively 
cost-e ective and easy to be performed, especially 
when a large number of DNA samples from top-level 
athletes and controls is readily available, which makes 
this approach interesting to initially screen potential 
candidate polymorphisms. In contrast, association 
studies do not provide cause-e ect relationships, 
meaning that establishing an association between a 
candidate polymorphism and elite athletic status is not 
su  cient to accept a candidate polymorphism as valid. 
 us, providing further evidence on the in uence 
of that polymorphism on physical performance it is 
extremely important.  is evidence can be produced 
using the cross-sectional and longitudinal prospective 
approaches detailed in the previous paragraph, as 
well as by determining a physiological role of the 
polymorphism on sports-related phenotypes.  e 
critical steps for producing compelling evidence 
on the role of a genetic variant in enhancing sports 
performance are schematised in FIGURE 2.
FIGURE 2 - Critical steps and experimental approaches necessary to validate a candidate gene as relevant to 
sports performance.
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Genome-wide studies
Although re lat ively cost-ef fect ive and 
straightforward, association studies often face 
some obstacles that may hamper researchers to 
securely draw conclusions from the data obtained. 
To circumvent these problems, some measures are 
recommended when performing association studies.
In some cases, a particular polymorphism correlates 
with athletic phenotypes in a group of individuals 
from a speci c region and, later, the same association 
is observed in a di erent set of individuals from a 
distinct region27-28.  is positive replication (i.e., a 
consistent association) strengthens the evidence for 
the in uence of the polymorphism on phenotype. 
However, even if the replication occurs in more 
than one population, it does not mean that the same 
association will be found in every population of the 
world29. In fact, associations found in a study are 
frequently not replicated in subsequent studies30-33. 
Depending on the characteristics of the studies that 
showed the association (e.g., sample size, ethnic 
background and homogeneity of athletic cohort in 
terms of competitive level and sports disciplines), 
such inconsistencies may be interpreted as: 1) the 
polymorphism is not relevant to physical performance; 
2) the polymorphism is relevant in a population with 
a speci c ethnic background; 3) the polymorphism is 
relevant for some speci c sports disciplines.
According to the ethnic background of the 
studies cohort, the frequency of each genotype can 
vary dramatically33-34.  erefore, all polymorphisms 
reported in the literature should be replicated in 
di erent populations4,16. It is possible that some 
polymorphisms are relevant to performance only 
in some speci c regions or under some speci c 
conditions, whereas other polymorphisms may have 
a more “universal” e ect.
One major disadvantage of candidate-gene 
studies is that only one or a few (in the case of 
polygenic pro le studies) genes can be assessed at 
a time. In view of this, new methods allowing the 
screening of the whole genome were developed. 
Genome-wide linkage studies (GWLS) were the 
 rst approach to analyse genetic markers across the 
entire genome.  is method identi es chromosomal 
regions that harbour genes a ecting quantitative 
traits over generations (i.e., it identi es quantitative 
trait loci)24. GWLS have been used to discover 
QTL associated with a variety of diseases and other 
phenotypes25. 
More recently, technological advances originated 
another technique, the so-called genome-wide 
association study (GWAS), capable of identifying 
genes, rather than genomic loci, associated with 
a phenotype35. Unlike GWLS, which requires 
familial data (the basic unit of observation is a pair 
of parents, usually brothers), GWAS studies analyse 
individual data24.  is new approach is becoming 
increasingly popular in the search for variations that 
contribute to complex traits24.
While candidate gene studies are driven by the 
theoretical impact that a variant would have on 
physical performance, GWAS do not make any 
prior assumption regarding genes and variants 
involved with physical performance2. Due to our 
limited ability to select candidate polymorphisms 
for association with performance based only on 
available theory, the design of candidate-genes 
association studies will be always restricted to a 
certain degree24. In this sense, the fact that GWAS 
studies are “theory-free” and that polymorphism 
selection is based on observational data makes this 
approach more robust.  is increases the chances 
of  nding new and perhaps unexpected genes and 
variants affecting physical performance, which 
might open new venues for investigation.
Despite being considered more robust than 
candidate genes studies, GWAS are very expensive 
and, therefore, not widely used in sports sciences or 
not used in truly large athletic cohorts35. In 2008, 
the cost of a run containing two human genomes 
(30x coverage - Illumina sequencing machine - 
HiSeq 2000) was around US $60.000 36. Even 
though this value has been falling and in 2011, 
the price of a similar run was around US $10.000 
36, meaning that a very large study with adequate 
statistical power would reach extremely high costs.
Because of the multivariate nature of GWAS, the 
p value must be times lower than usual to accept the 
correlation as signi cant (normally 5x 10-8 rather 
than 0.05) 2,37, which obviously require a very large 
sample size to achieve a desirable statistical power. 
By their very nature, cohorts of fairly homogenous 
top-elite athletes are small.   us, reaching desirable 
statistical power in GWAS studies can be an 
enormous challenge in sports sciences.  e study by 
Pitsiladis and Wang36 describes a good example 
on how sample size can a ect GWAS outcomes, 
reporting two studies designed to quantify the 
heritability of stature, a very stable and easy to be 
measured variable, using the GWAS approach. In 
one study, a set of ~30,000 individuals was analyse
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and it was found that less than 5% of the variation in 
the phenotype is explained by genetics. In contrast, 
the other study using a much larger set of individuals 
(n ≅ 180.000) showed that genetics explained 10% 
of the variance in height.
Likewise, the number of SNPs included in the 
analysis a! ects the GWAS statistical power.  e 
greater the number of SNPs, the greater the number 
of comparisons carried out by statistical analysis, so 
the value accepted to consider statistical signi cance 
is reduced16. Another limitation of GWAS is that, 
despite screening for genetic variants along the entire 
genome, only SNPs are detected in this analysis, 
meaning that not all types of genetic variations will 
be captured4,24, such as copy number variants.
A massive amount of information is generated 
by one GWAS. However, as with any other 
association study, the results of GWAS can be 
vague or uninformative38. Within the same study, 
the following situations can be possible: 1) a 
signi cant association is found between a SNP and 
a phenotype, and the result is replicated in other 
cohorts (true-positive); 2) a signi cant association 
between the SNP and the phenotype is found, but 
replication studies fail to con rm it in other cohorts 
(false-positive) ; 3) GWAS was not sensitive enough 
to detect associations which were already con rmed 
in previous studies (lost-results)38. It has been shown 
that non-replicating results and inconsistency in the 
magnitude of results (heterogeneity) are commons 
 aws in GWAS38.
In the last 5 years, several investigations were 
carried out using GWAS for complex phenotypes, 
mainly pathologies35. In 2011, Bouchard et al.39 
conducted the # rst study applying GWAS in a 
group of individuals (non-athletes) before and after 
a training period. " ey examined the association of 
SNPs with the VO
2max
 responses to physical training. 
" e authors managed to perform the study in a quite 
large sample (> 1000 subjects) and to compare the 
results in di erent cohorts. " e study successfully 
identi# ed genetic variants associated with training 
responses, and then it was possible to construct a 
panel of 21 SNPs, which accounted for 49% of the 
variance in VO
2max 
responses (p < 0.05). To date, 
there are no studies using the GWAS approach in 
a cohort of athletes. Although it is acceptable that 
access to large cohorts of truly elite athletes represents 
a tremendous barrier to high-quality genome-wide 
studies in this population, a collective e ort from 
research groups around world is indeed necessary 
to undertake this extremely relevant type of study.
The role of sample size
" e number of participants is probably the most 
important limitation of genetic association studies26, 
especially when referring to elite athletes40. Because 
performance-relevant polymorphisms are normally 
found in low frequencies in a given population12, 
reduced sample sizes will probably return very small 
numbers of individuals presenting the rare genotype. 
Each polymorphism exhibits distinct frequencies in 
di erent populations, so the sample size necessary 
to detect an association can vary according to the 
polymorphism and to the population analysed17,41. 
Sample size is directly related to the statistical power 
of the study, and a reduced number of participants 
can hamper the drawing of # rm conclusions4. " is 
limitation becomes even more evident when multiple 
comparisons enter into statistical model (e.g., in GWAS 
and polygenic studies), which makes the analysis more 
rigid and lowers the set level of signi# cance16.
Some authors claim that this limitation is justi# able 
since there is a very limited number of high-level 
athletes in most regions and countries. " is makes 
the collection of a su@  ciently large cohort almost 
impossible and it explains why studies with elite 
athletes usually assess a small number of individuals 
(i.e., n > 100)42. Indeed, this is a very strong and 
truthful argument and, regrettably, no much can be 
done to enlarge athletic cohorts, especially in countries 
where competitive sport is less prominent. However, 
researchers in this area should endeavour to maximize 
the number of athletes in their cohorts. In fact, some 
authors advocate that the research groups around the 
world should create an international consortium with 
DNA samples from worldwide elite athletes4,16. " is 
is probably the best way to circumvent this relevant 
limitation in sample size. However, researchers should 
be conscious to the fact that this procedure could 
result in heterogeneous groups regarding both athletic 
and ethnic backgrounds, which would add extra 
confounding variables to the analysis.
Alternatively, increasing the number of participants 
in the non-athletic (control) group can be an 
appealing manner to minimize problems with low 
sample sizes and underpowered studies. For example, 
by running a statistical simulation, we observe that a 
group of athletes (n = 100; frequency of the rare allele 
= 30%) when compared to a control group (n = 100; 
frequency of the rare allele = 20%), no signi# cant 
di erences are observed for the allele frequency 
between groups (x2 = 2.16, p = 0.14). However, as 
shown in FIGURE 3, even if the number of athletes 
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remains unchanged (n = 100; frequency of the rare 
allele = 30%), it is possible to detect a signi cant 
di erence between groups by increasing the number 
of controls to 325 (frequency of the rare allele 
remains 20%) (x2 =  3.85, p = 0.0497). As displayed 
in FIGURE 3, successive increases in the number of 
controls are paralleled by increases in statistical power. 
However, at a certain point, further large increases in 
sample size result in merely slight increases in power. 
In view of this, researchers are advised to increase the 
number of controls to a maximum in their analysis. 
Possibly, a control sample size between 1000 and 
1500 will yield a desirably good statistical power for 
the majority of the situations.
FIGURE 3 - Level of signiﬁ cance found considering a ﬁ xed sample of athletes and varying the amount of non-
athletic subjects (controls).
The importance of making comparisons
between homogeneous groups
It is widely accepted that each sport discipline 
has its particular physiological, psychological, 
anthropometrical and biomechanical demands, 
which directly in uence the characteristics that 
would most contribute to competitive success43-45. In 
fact, it has been considered that the polymorphisms 
in uencing endurance sports are di erent from the 
polymorphisms in uencing sprint sports, which 
display a greater demand for muscle strength and 
power46. Considering that some (if not all) of these 
characteristics are in part genetically determined, 
studies comparing genotypes between athletes 
should carefully select which sports disciplines will be 
included in a given group when categorizing athletes. 
Most studies have been categorized athletes 
into two opposing groups, namely sprint/power-
orientated sports vs. endurance-orientated sports31,47. 
Although this is an interesting approach, since it 
would group together sports under the in uence of 
the same genes and polymorphisms, the inclusion of 
sports in the same group that are not really analogous 
can represent a major flaw in the analysis. For 
example, football, 200-m swimming and powerlifting 
could be classi ed as power/sprint-orientated sports, 
even though the determinants of these disciplines are 
clearly di erent. Even nearly identical sprint/power-
orientated sports could have quite di erent demands, 
such as 50-m and 400-m swimming. In view of this, 
it becomes evident that researchers should wisely 
include in the same group only athletes who compete 
in truly comparable disciplines.
The study by Muniesa et al.48 compared 
the distribution of 6 polymorphisms between 
endurance runners (> 5000 meters) and endurance 
cyclists, sports that are usually clustered on the 
same group due to their similar metabolic demand. 
Interestingly, the frequency of the I and D alleles 
(indel polymorphism in the ACE gene) was di erent 
between these groups. Despite the similarities 
regarding the metabolic demands, factors such as 
mechanical e+  ciency and movement economy may 
have in uenced the di erential role of the ACE 
polymorphism in these sports48.
Another matter of concern is how to categorize 
athletes according to competitive levels. Ideally, a 
polymorphism that exerts some in uence on sports 
performance should be capable of di erentiating not 
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Most studies on genetics of sports performance 
have assessed the impact of only one variant on 
athletic performance46. Due to the multifactorial 
nature of sports performance, the e ect of a single 
variant is most likely to be small49. According to 
Flueck et al.50, one important drawback of the 
single gene approach in sports sciences is that the 
selected gene may only marginally contribute to 
performance, or it may not be the “bottleneck” 
of performance, since many other genes may 
compensate the altered function of the polymorphic 
gene.  e regulation of every physiological system 
involved in exercise performance and training 
responses is dependent on a complex network of 
interconnected genes51.  us, it is assumed that the 
contribution of genetics to physical performance 
relies on the combined action of di erent genes and, 
consequently, a number of di erent polymorphisms 
Single gene approach 
vs. polygenic proﬁ le
only athletes from non-athletes, but also elite athletes 
from non-elite athletes.  us, the criteria utilised to 
categorise athletes into competitive groups can be also 
confounding factors in association studies. Usually, 
“high-elite” athletes are those who participate in 
Olympic Games or World Championships; “elite” 
are those who participate in international-level 
competitions (e.g., continental championships), 
“sub-elite” participate at the national-level; and 
“non-elite” in state- and regional-level competitions. 
Although slightly di erent classi! cations have been 
used in literature40, this is an easy and straightforward 
manner to classify athletes according to competitive 
levels. However, researchers from di erent countries 
should be cautious in relation to how a particular 
sport is developed in that country. For example, 
judo is a very popular and developed sport in Brazil, 
whilst rugby is not. On the other hand, judo is not 
a popular and developed sport in New Zealand, 
whereas rugby is probably the most prominent sport. 
In this context, reaching national judo level in Brazil 
is probably more di"  cult than reaching international 
high-elite levels in judo in New Zealand. Likewise, 
a world-cup rugby player in Brazil would probably 
have less of the necessary characteristics to succeed 
in rugby than a national-level New Zealand athlete. 
Because of these national disparities, authors should 
ponder the most appropriate way to classify the 
athletes from theirs cohorts taking into consideration 
how the speci! c sport is developed.
accounts to the variation in sports excellence and 
training responses.
Despite their limitations, single gene studies 
are important to first identify polymorphisms 
associated with performance, especially when it is 
not possible to perform GWAS. However, because 
one single polymorphism would only account for 
a minor part of the total variation, a combination 
of polymorphisms (i.e., a polygenic pro! le) would 
provide a better model to explain how changes at the 
molecular level in DNA would a ect the phenotype.
 e concept of polygenic pro! le is now becoming 
more solid. It was recently shown that healthy 
individuals who possess more alleles associated with 
aerobic metabolism present better responses to 
aerobic training (according to VO
2max 
responses to 
training)39. Likewise, endurance athletes with a greater 
amount of alleles already associated with endurance 
performance have a greater chance of being successful in 
endurance-orientated sports52.  erefore, it is becoming 
increasingly clear that high-level athletes are individuals 
genetically distinguished, meaning that they probably 
present a combination of numerous polymorphic 
alleles associated with physical performance12.
In 2008, Williams and Folland17 proposed the 
calculation of the total score genotyping (TGS). 
To calculate TGS, the polymorphisms that have 
been previously associated with a target phenotype 
must be selected. Each allele receives a score, 
which ranges from 0 to 2, according to the existing 
genotype. Homozygous genotypes associated with the 
phenotype receive the score “2”, while heterozygotes 
receive the score “1”. Homozygous for the allele not 
associated with performance returns the score “zero”. 
After determining the scores for each polymorphism, 
these are summed and the result is expressed in a scale 
ranging from 0 to 100, so that the TGS is obtained. 
Using this score, it is possible to assess the balance 
between several selected di erent polymorphisms that 
are knowingly relevant to performance41.
From 2009 to the present day, the TGS has been 
used by some research groups and has proved to 
be a sensitive tool to di erentiate endurance from 
strength/power athletes31,47,53-54. Additionally, the 
use of TGS has revealed that high-elite athletes have 
a polygenic pro! le signi! cantly di erent from the 
general population, which probably makes athletes 
more favourable to sports success18.
 e TGS assumes a dose-response e ect, i.e., 
the more associated alleles an athlete has, the 
better his/her genetic pro! le for sports success. 
Hence, it is assumed that there is an additive e ect 
186 • Rev Bras Educ Fís Esporte, (São Paulo) 2014 Jan-Mar; 28(1):177-93
Guilherme JPLF, et al.
of polymorphisms4. Moreover, the sensibility of 
the TGS to di erentiate individuals with di erent 
genetic predisposition to excel in a given type of 
sport seems to be dependent on the number of 
polymorphisms included in the calculation18. 
 e choice of which polymorphisms are included 
in the TGS calculation should be made in light of 
the characteristics of the studied population. For 
example, if a study aims to determine the polygenic 
profile of sprinters, polymorphisms associated 
with muscle size and strength, as well as anaerobic 
energy metabolism and other sprint-orientated 
phenotypes should be inserted in the formula41. 
Besides, the choice of the polymorphisms should 
include only those truly consistently associated with 
the phenotype. Otherwise, the TGS will lack power 
in di erentiating athletes between non-athletes or 
sprinters endurance athletes17,41.
A potential limitation of the TGS is the fact that 
it considers all polymorphisms as in uencing athletic 
performance to the same extent4. With the currently 
available knowledge, it is impossible to determine 
the exact weight that each polymorphism should 
have in TGS calculation, simply because it is not yet 
determined the weight of each polymorphism in the 
regulation of the di erent sports-related phenotypes55. 
 e number of genes that are modulated in response 
to physical training is relatively large. In contrast, the 
scienti c literature shows a relatively limited number of 
polymorphisms associated with physical performance 
in athletes, i.e., about 20 genes17,41.  e scores so far 
published have included 6-10 polymorphisms in the 
TGS calculation, which clearly represents only a small 
fraction of the genes that putatively a ect sports-
related phenotypes52,56. As a consequence, the optimal 
combination of polymorphisms that would result in an 
ideal TGS model is yet to be determined49. However, 
this does not preclude the TGS to be successfully 
used to distinguish endurance athletes from strength/
power athletes and from non-athletes. Furthermore, 
the TGS will probably be updated and optimized in 
the upcoming years as the knowledge on single genes 
associated with performance will improve42. One 
important caveat, however, is that as the number of 
polymorphisms is included in the calculation increases, 
the likelihood of  nding an individual with optimum 
genotypes decreases exponentially17,41, which could 
cause TGS to lose sensitivity.  us, an ideal model of 
TGS will include only the genes that most contribute 
to that speci c trait.  e exact number and the most 
important genes for each phenotype are fundamental 
questions that researchers should address in the future.
Identiﬁ cation of new candidate polymorphisms
To choose a new polymorphism that will be 
analysed in an association study, it is  rst necessary 
to choose a candidate gene to be explored. A 
convenient way to choose a candidate gene is to 
observe which genes are modulated during or 
after exercise 57. If a particular gene is consistently 
modulated, it would be worthy to search for 
structural variations in this gene that could in uence 
phenotypes related to physical performance58.
Recently, Timmons et al.57 screened, through 
the use of microarray, the mRNA expression in 
“vastus lateralis” muscle of healthy subjects who 
underwent 20 weeks of aerobic training. Afterwards, 
the authors searched for polymorphism in the genes 
whose expression accounted for the variation in 
VO
2max
 responses. Six SNPs that may account for 
the variability in the cardiorespiratory response to 
aerobic training were identi ed.
Although useful, microarrays are somewhat 
expensive and time-consuming. The enormous 
amount of data generated might also represent 
another obstacle to the use of this technique. In 
order to identify new candidate polymorphisms 
influencing athletic performance, alternative 
methods other than microarrays can be employed. 
A considerable amount of information on mRNA 
expression and exercise is available in literature and 
potential genes are waiting to be explored59.
After choosing one candidate gene to be explored, 
an investigator should examine all genetic variations 
described for the gene, which can easily be done with 
online public databases (e.g., NCBI and UCSC)4. 
For the vast majority of the genes, several structural 
variations will be found, including single nucleotide, 
indel and copy number polymorphisms.  e selection 
of the best candidates should consider previously 
available data. Nonetheless, multiple polymorphisms 
for each gene should be tested in order to verify which 
one presents the best correlation with the phenotype25. 
 ere is a natural tendency in sports research to 
study genes involved in motor activities. However, 
more recent studies indicate that genes involved 
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Strategies to identify physiological roles of a polymorphism
As previously discussed, unravelling the 
underlying physiological mechanisms by which 
a genetic variant a ect performance is crucial to 
de nitively associate that variant to performance. 
However, this is often a very laborious and elusive 
task. Nevertheless, a few experimental approaches 
might be of great use for this purpose.
Knowing whether the structural DNA variant 
a ects or not gene and protein expression at the tissue 
level is probably the most fundamental question. If 
the polymorphism severely a ects protein structure 
(e.g., a non-sense or a frameshift polymorphism), it 
is usually easier to observe its impact on physiology 
and on phenotype. In fact, the best-characterized 
polymorphism impacting physical performance is 
the R577X in the ACTN3 gene, which is a non-sense 
polymorphism leading to the synthesis of a non-
functional protein63. ! is is because the absence of 
the alpha-actinin-3 protein in humans carrying both 
polymorphic alleles can be mimicked in knockout 
animals, providing a very interesting model to 
evaluate how the lack of the protein impacts muscle 
structure, muscle metabolism and performance64. 
However, most polymorphisms are SNPs, indel or 
copy number variants, and they may occur at non-
coding genomic regions. Consequently, their impact 
on protein structure is less evident and the creation 
of a good animal model is often unfeasible. In these 
cases, human studies are indeed necessary. 
! e knowledge of the tissues and cells where the 
polymorphic gene is expressed should dictate the best 
approach to examine how the polymorphism a ects 
gene and protein expression. For example, considering 
a variant in a gene that expresses exclusively in skeletal 
muscle, then muscle biopsies should be collected 
from a group of individuals with all genotypes. ! ese 
samples could be submitted to a variety of analysis, 
including gene expression (e.g., qPCR), protein 
expression (e.g., western blotting), and morphological 
inspection (e.g., light or electron microscopy). Further 
analysis should also be carried out depending on the 
role of the gene. Exemplifying, if the gene encodes for 
an enzyme, then comparing enzyme activity between 
genotypes is probably a very reasonable approach. 
Obviously, in some cases human tissue collection is 
not an option, especially if the gene is expressed in 
heart, bone, kidney, liver brain or any other organ 
where a biopsy is too invasive and unjusti able. ! is 
would imply the necessity for alternative and more 
indirect approaches. ! ese scenarios illustrate quite 
well how di  cult establishing a physiological link 
between a polymorphism and a phenotype can be.
In cases that an animal model can be generated so 
the genetic variation in humans is properly mimicked, 
acceptable sample sizes for these animal studies are 
substantially low, since all other sources of variation 
are controlled. In contrast, when human studies are 
performed and groups of individual with di erent 
genotypes are compared, sample size becomes 
critical. Because studies with humans, especially the 
cross-sectional ones, normally have poor control 
of major intervenient variables (e.g., diet, exercise 
background, genetic background, use of medications 
and development conditions), it is imperative that all 
genotypes have a large enough number of participants 
in order to minimize the chances of groups being 
di erent due to confounding factors rather than to 
genotype itself. In this case, the importance of large 
samples is not only about statistical power, but to 
conveniently decrease the likelihood of assuming that 
genotype groups are di erent when the cause of the 
di erence is not the genotype “per se”.
in psychological characteristics may also in# uence 
athletic performance60-61. Some prime examples are 
the genes 5HTT, BDNF and UCP262 and future 
studies should start focusing on the psychological 
aspects implicated in sports performance when 
selecting new candidate genes.
Genetic interactions
A still unexplored, yet interesting and promising 
area of research in sports genetics is how genes 
interact with other genes to modulate exercise 
responses or to modulate a phenotype that is strongly 
related to performance4. It is well recognised that 
genes do not act in isolation. Rather, there are 
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Rare variants
It is well accepted that the in uence of common 
genetic variants on performance is slight, but the 
combination of several polymorphisms probably is 
more in uential16. On the other hand, it is highly 
plausible that rare genetic variants or mutations may 
eventually confer a very signi cant advantage to 
performance. Rare variants, therefore, are probably 
a very important aspect of the genetic variability 
that underlies sports excellence. However, due to 
the extreme di  culty to identify and characterize 
these variants, this is still poorly understood15.
In most instances, mutations lead to loss of 
function, disease or disabilities, which adversely 
a ects sports-related phenotypes24. A good example 
is the mutation found in the PYGM gene that 
results in a deficit in carbohydrate metabolism 
(i.e., McArdle’s disease) and, as a consequence, the 
patient presents intolerance to physical exercise. 
Many other examples of mutations that would cause 
incompatibility with athletic phenotypes could be 
provided. However, not all mutations are detrimental 
to physical performance. ! e notorious case of a 
mutation resulting in the absence of the myostatin 
protein illustrates how a rare variant can represent 
an extreme advantage to some performance-related 
phenotypes without causing any harm to health65. It 
must be noted, however, that it is currently unknown 
whether this speci c mutation in the myostatin gene 
is in fact favourable to physical performance. 
Because each rare variant will be carried by no more 
than a few individuals, identifying these rare variants 
and correlate them to a speci c sports-related phenotype 
is not an easy task. Nonetheless, e orts should be made 
in order to identify new rare variants and broaden our 
knowledge about the genetics of the sports excellence. 
Maybe performing a genome-wide scan of individuals 
presenting abnormally high phenotypes such as muscle 
mass, strength,  exibility and aerobic capacity and 
extraordinarily excellent performance in sports is a 
reasonable approach to search for new rare variants.
The use of genetic markers to detect sports talent
! e molecular mechanisms in uencing athletic 
performance take place and are regulated by genes; 
these are gradually being revealed. Some authors argue 
that testing for the presence of key genetic variants in 
youth can be used as a way to select potential athletes61. 
! e early identi cation of potential elite athletes could, 
in theory, optimize training plans and competitive 
stimuli during growth and development, therefore 
increasing the chances of reaching the peak of physical 
performance61. ! is process of identifying talent by 
means of polymorphisms (genetic testing) could, in 
principle, be revolutionary to the  eld of sport25.
! e publication of Yang et al.66 describing the 
in uence of the polymorphism R577X in ACTN3 
gene on athletic performance had a major impact on 
the scienti c community and in general population. 
Some authors67 have stated that the association of 
ACTN3 with the physical performance is su  cient 
for using this polymorphism as a tool to select 
potential athletes. In 2004, just one year after 
complex interactions among many genes modulating 
phenotypes42. Some polymorphisms might not have 
a meaningful impact on athletic performance alone, 
but the presence of other polymorphisms, through 
gene-gene interactions, may enlarge its impact 
upon phenotype, so that not a presence of a single 
polymorphism but, instead, the combination of some 
speci c polymorphisms may be potentially bene cial 
to some performance- related  phenotypes4.
In addition to the interactions between genes, 
gene-environment interactions must be taken into 
consideration in future research, especially in light of 
the multifactorial nature of sports performance. After 
certain environmental stimuli, some polymorphisms 
may have greater or lesser in uence on the responses 
to those stimuli26. ! e replication of the results in 
di erent cohorts, under di erent environmental 
stimuli, is an indirect way to assess this interaction. 
! e researchers’ primary e orts have been focused 
on the discovery of novel polymorphisms with the 
capability to in uence physical  tness components. 
Subsequently establishing a panorama for one or 
more polymorphisms, possible gene-gene and gene-
environment interactions should be investigated.
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the publication of Yang and colleague’s paper, an 
Australian company and after, in 2008, an American 
company began to develop and sell, at a cost of 
US $170, claiming that the genetic test would 
determine to which sport the person would have a 
higher “vocation”68. Currently, there are at least 7 
companies that sell genetic tests, now with a broader 
range of polymorphisms being o ered61.
Despite the strong appeal of these genetic tests, 
the information provided by them is useless to 
anyone who seeks the competitive career in any 
sport. As discussed throughout this paper, sports 
performance is multifactorial. Genetics comprises 
only one of many contributing factors. Moreover, 
the genes and variants that may have a positive e ect 
on performance are numerous, all of them under 
the regulation of an extremely complex network 
of other genes and variants, among other factors. 
 erefore, the presence or the absence of a few 
polymorphisms will never have such a predictive 
power.  e literature presents many good examples 
of very successful athletes who, nevertheless, 
presented a genetic pro le that could be considered 
“unfavourable”. Regarding the ACTN3, which is 
one of the best-characterized polymorphisms69, 
there are athletes achieving great results in strength 
activities that do not display the RR genotype70.
 e Council of Europe Bioethics Convention 
and the Genetic Information Non-Discrimination 
Act in the US consider the use of the genetic testing 
to predict performance an unethical action and they 
are currently evaluating whether they should be 
banned71. Besides the absence of scienti c validity and 
the lack of useful information, three other important 
ethical issues must be highlighted in relation 
to information misuse: 1) the autonomy of the 
individual to not to know their genetic information, 
since some polymorphisms associated physical 
performance may also be associated with diseases; 2) 
invasion of privacy, as a personal information can be 
passed to other people and used in a discriminative 
way; 3) professional misconduct and diminished 
opportunities, as coaches and trainers may not be 
willing to invest their time and e orts in an individual 
without “genetic predisposition” to sports61.
With the intention to find gifted individuals 
at early stages, the major target of genetic testing 
would be children and youths. Some authors point 
that fanatic relatives could take their children to 
train very hard, if they believe that the children have 
more changes based on results of genetic testing72. 
Knowingly, excessive training loads at young 
ages could represent a health harm, and result in 
overtraining, burnout and sport abandonment73. It is 
important to note that, as highlighted by Hawley74, 
the athlete who knows your genetic information may 
feel discouraged to keep practicing, especially if the 
information is negative for his/her expectation.
A potential use of genetic testing is related to 
the individualized prescription of exercise26. Several 
researchers argue that genetics should be used as 
an aid for improving exercise prescription and 
optimizing training responses in non-athletes75-80. 
Although some authors have already published 
training recommendations according to athletes’ 
genotype67, it must be noted that there is no 
currently available information to support any 
genotype-directed training for athletes. In fact, there 
is no study addressing how genotypes in( uence 
training responses in athletes. Although in principle 
the proposal of genetic tests is revolutionary, at the 
moment, we still have no evidence supporting the 
creation of any model with acceptable predictive 
value. At present, the use of genetic tests has no 
advantage over the traditional methods for talent 
identi cation already used by trainers25.
Conclusion
conscious about the implications of the misuse of 
the genetic information. While some people may 
claim that genetic information could be used to 
detect talent and to drive athletic development, it 
must be noted that there is no scienti c evidences 
for the predictive value of genetic in sports.  e most 
appropriate statement at the moment is that genetics 
is only one out of many contributing factors to the 
athletic performance, and sometimes it may play only 
 e future of genetic studies involving athletes 
is promising. In recent years, many polymorphisms 
have been associated with athletic phenotypes, 
but de nitive con rmation of association and the 
underlying physiological mechanisms are proven 
di*  cult tasks.  e challenges to progress in this novel 
area are enormous, but a variety of experimental 
approaches can be used to unravel part of the mystery. 
Researchers and the general population should be 
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